Europe Prescription Drugs

• Anti-Suicide Drugs Market, by Drug Class (Anti-Depressant and Anti-Anxiety Drugs, Anti-Psychotic Drugs, NMDA Antagonist, Antibiotic Analog), by Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa) - Size, Share, Trends, and

  May 03, 2022  |  Published by: Coherent Market Insights  |  USD 4,500

  ... 2022 - 2028 Suicidal thoughts can be aroused due to various underlying factors such as financial burden, social issues or drug side effects. Treatment for suicidal thoughts includes psychotherapy, medications, addiction treatment, and family support. ... Read More

• Europe Adalimumab Market - Industry Trends and Forecast to 2029

  May 01, 2022  |  Published by: Data Bridge Market Research  |  USD 3,500

  ... data for the historic year 2020, the base year of calculation is 2021 and the forecast period is 2022 to 2029. Market Segmentation: Europe Adalimumab Market, By Indication (Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, Psoriatic Arthritis, ... Read More

• Europe Dry Eye Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Artificial Tears, Antibiotic Drops, Hormone Drops, and Others) and Type (OTC Drugs and Prescription Drugs)   

  Apr 20, 2022  |  Published by: The Insight Partners  |  USD 3,000

  ... market in Europe is expected to grow from US$ 1,993.06 million in 2021 to US$ 2,781.56 million by 2028; it is estimated to grow at a CAGR of 5.1% from 2021 to 2028. The incidence ... Read More

• Benzodiazepine Drugs Market, by Product (Long Acting Benzodiazepine {Chlordiazepoxide, Diazepam, Lorazepam, Alprazolam, Clonazepam, and Others}, Short Acting Benzodiazepine {Temazepam, Midazolam, Triazolam and Others), by Application (Anxiety Disorders, Nervousness, Sedation, Seizures, Alcohol Withdrawal and Others), by Route of Administration (Oral, Injectables, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

  Apr 12, 2022  |  Published by: Coherent Market Insights  |  USD 4,500

  ... Route of Administration (Oral, Injectables, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, ... Read More

• Europe Benign Prostatic Hyperplasia Therapeutics Market Size, Share & Industry Trends Analysis Report By Therapy (Mono Drug Therapy and Combination Drug Therapy), By Therapeutics Class, By Country and Growth Forecast, 2021 - 2027

  Feb 28, 2022  |  Published by: Knowledge Based Value (KBV) Research  |  USD 1,500

  ... Benign Prostatic Hyperplasia Therapeutics Market would witness market growth of 3.9% CAGR during the forecast period (2021-2027). BPH is neither a malignancy nor a cause of prostate cancer. BPH, on the other hand, can be ... Read More

• Meningococcal Disease Treatment Market, By Therapy Type (Antibiotics (Penicillin, Ampicillin, Chloramphenicol, and Ceftriaxone) and (Vaccines (Bivalent, Trivalent, and Tetravalent)), By Route of Administration (Injectable and Oral), By Distribution channel (Hospital Pharmacy, Retail Pharmacy, and Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

  Feb 04, 2022  |  Published by: Coherent Market Insights  |  USD 4,500

  ... and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028 Meningococcal infection is a bacterial infection caused by Neisseria meningitidis, also ... Read More

• Netherlands Pharmaceutical Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  Jan 17, 2022  |  Published by: Mordor Intelligence Inc  |  USD 4,750

  ... presence of world-class research institutes, a highly educated workforce, an excellent healthcare system, and an innovation-friendly government, combined with a central location makes the country an ideal base for biopharmaceutical operations. Healthcare and medicine spending ... Read More

• Syndicated Quarterly Diabetes Market Share Tracker Europe

  Mar 31, 2020  |  Published by: Quomeda Ltd.  |  USD 25,000

  ... sizes and market share by brand with NPS score. Includes drivers and barriers, types of usage and patient preferences, brand attributes ranking, plus country-specific reimbursement landscape and changes, digital health/diabetes apps chapter. In it's fourth ... Read More

< prev 1 2 3 4 5 6 next >